{
    "id": "0548",
    "question": "A 24-year-old man, who recently migrated from a developing country, presents to a physician because of a 2-year history of cough, blood in his sputum, fever, and weight loss. His sputum smear and culture confirm the diagnosis of pulmonary tuberculosis due to Mycobacterium tuberculosis. His Mantoux test is 2 mm \u00d7 3 mm, and his chest radiograph is normal. High-sensitivity enzyme-linked immunosorbent assay for HIV-1 and Western blot assay for HIV-1 are positive. His CD4+ T cell count is 90/\u03bcL and HIV RNA is 30,000 copies/mL. He is started on a 4-drug regimen consisting of isoniazid, rifampin, pyrazinamide, and ethambutol in appropriate doses. He becomes sputum smear-negative after 4 weeks and reports significant improvement in symptoms. After another 4 weeks, the physician removes pyrazinamide from the antitubercular regimen and adds antiretroviral therapy (dolutegravir/tenofovir/emtricitabine). After 3 weeks, the patient presents with complaints of fever and significantly increased cough for 3 days. There is no respiratory distress but generalized lymphadenopathy is present. His chest radiograph shows pulmonary infiltrates and mediastinal lymphadenopathy, sputum smear is negative, Mantoux test is 12 mm \u00d7 14 mm, CD4+ T cell count is 370/\u03bcL, and HIV RNA is 2,900 copies/mL. What is the most appropriate initial step in treatment?",
    "options": {
        "A": "Stop antiretroviral therapy and continue antitubercular therapy",
        "B": "Change antitubercular therapy to isoniazid-rifampin-pyrazinamide-ethambutol-streptomycin",
        "C": "Change antitubercular therapy to isoniazid-rifampin-ethambutol-streptomycin",
        "D": "Continue antitubercular therapy and antiretroviral therapy without any change"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"The patient has been on antiretroviral therapy (dolutegravir/tenofovir/emtricitabine) for 3 weeks and presents with symptoms of fever, cough, and generalized lymphadenopathy, along with pulmonary infiltrates and mediastinal lymphadenopathy on the chest radiograph. This suggests a possible reactivation of tuberculosis (TB) due to the compromised immune system of the patient. The patient's CD4+ T cell count has increased from 90/\u03bcL to 370/\u03bcL, indicating some improvement in immune function. However, the patient is still considered immunocompromised due to the low viral load (HIV RNA 2,900 copies/mL). The patient's sputum smear is negative, but the clinical presentation and radiographic findings suggest TB reactivation. The most appropriate initial step is to change the antitubercular therapy to a regimen that is more effective in treating TB in immunocompromised patients. The first-line regimen for TB in patients with HIV is the Isoniazid-Rifampicin-Ethambutol-Streptomycin (IRD) regimen, which is less toxic and more effective in immunocompromised patients. Changing the antitubercular therapy to IRD is the most appropriate initial step in treatment.\", \"answer_choice\": \"C\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 28.589476108551025
}